Affymetrix to Webcast Presentation at UBS Global Life Sciences Conference
September 16 2008 - 9:00PM
Business Wire
Affymetrix Inc. (NASDAQ:AFFX) today announced that Kevin King,
president of Affymetrix, will provide a company overview at the UBS
Global Life Sciences Conference on September 23, 2008 in New York
City, NY. A live webcast of the presentation will take place at
4:00 p.m. ET. To access both the live and archived webcasts, please
go to www.affymetrix.com and click on the "Investors" link under
the �Resources for� dropdown. An archived webcast of the
presentation will be available for 30 days. About Affymetrix
Affymetrix GeneChip(R) microarray technology is the
industry-standard tool for analyzing complex genetic information.
After inventing microarray technology in the late 1980s, Affymetrix
scientists have been dedicated to developing innovative products
that provide researchers with a more complete view of the genome.
These products continue to accelerate genetic research and enable
scientists to develop diagnostics and tailor treatments for
individual patients by identifying and measuring the genetic
information associated with complex diseases. Today, Affymetrix
technology is used by the world's top pharmaceutical, diagnostic
and biotechnology companies, as well as leading academic,
government and not-for-profit research institutes. More than 1,700
systems have been shipped around the world and more than 13,000
peer-reviewed papers have been published using the technology.
Affymetrix is headquartered in Santa Clara, Calif., and has
manufacturing facilities in Sacramento, Calif., Cleveland, Ohio,
and Singapore. The company has about 1,100 employees worldwide and
maintains sales and distribution operations across Europe and Asia.
For more information about Affymetrix, please visit the company's
website at www.affymetrix.com.
Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Jul 2023 to Jul 2024